BETA-MIMETIC DRUG AND HUMAN-FETAL LUNG MATURATION

被引：13

作者：

CABERO, L

GIRALT, E

NAVARRO, E

CALAF, J

CABERO, A

DURANSANCHEZ, P

ESTEBANALTIRRIBA, J

机构：

[1] Servicio de Obstetricia y Ginecologia, Hospital de la Santa Cruz y San Pablo, Universidad Autonoma, Barcelona

来源：

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1979年 / 9卷 / 04期

关键词：

betamimetic drugs; lung maturity; palmitic acid;

D O I：

10.1016/0028-2243(79)90066-2

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

In a double-blind and randomized study the administration of a betamimetic drug to the mother from week 33 to 35 produces a significant increase in amniotic fluid palmitic acid levels. We suggest that the administration of a betamimetic drug during pregnancy to the mother can be useful in producing an acceleration of the fetal lung maturation. © 1979.

引用

页码：261 / 263

页数：3

共 5 条

[1] BETA-MIMETIC DRUGS AND POSSIBLE PREVENTION OF RESPIRATORY-DISTRESS SYNDROME [J].

BOOG, G ;

BRAHIM, MB ;

GANDAR, R .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1975, 82 (04) :285-288

[2] ORCIPRENALINE AND FETAL LUNG MATURATION IN RABBITS [J].

CABERO, L ;

ALEMANY, JR ;

QUILEZ, M ;

RIERA, R ;

NAVARRO, E ;

TORNER, A ;

DURANSANCHEZ, P ;

ESTEBANALTIRRIBA, J .

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1977, 7 (06) :357-358

[3]

CABERO L, 1976, CLIN INVEST GINEC OB, V3, P169

[4]

CABERO L, UNPUBLISHED

[5] ASSESSMENT OF FETAL LUNG MATURITY BY AMNIOTIC-FLUID FATTY-ACID ANALYSIS [J].

WARREN, C ;

ALLEN, JT ;

HOLTON, JB .

CLINICA CHIMICA ACTA, 1973, 44 (03) :457-459

← 1 →